KR20100017565A - (ｒ)-2-메틸피롤리딘 및 (ｓ)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법 - Google Patents

(ｒ)-2-메틸피롤리딘 및 (ｓ)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법 Download PDF

Info

Publication number
KR20100017565A
KR20100017565A KR1020097025141A KR20097025141A KR20100017565A KR 20100017565 A KR20100017565 A KR 20100017565A KR 1020097025141 A KR1020097025141 A KR 1020097025141A KR 20097025141 A KR20097025141 A KR 20097025141A KR 20100017565 A KR20100017565 A KR 20100017565A
Authority
KR
South Korea
Prior art keywords
methylpyrrolidine
methyl
tartrate
phenyl
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020097025141A
Other languages
English (en)
Korean (ko)
Inventor
마이클 크리스티
조세프 제이. 페트라이티스
Original Assignee
세파론, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세파론, 인코포레이티드 filed Critical 세파론, 인코포레이티드
Publication of KR20100017565A publication Critical patent/KR20100017565A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
KR1020097025141A 2007-05-03 2008-05-02 (ｒ)-2-메틸피롤리딘 및 (ｓ)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법 Ceased KR20100017565A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
US60/927,356 2007-05-03

Publications (1)

Publication Number Publication Date
KR20100017565A true KR20100017565A (ko) 2010-02-16

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097025141A Ceased KR20100017565A (ko) 2007-05-03 2008-05-02 (ｒ)-2-메틸피롤리딘 및 (ｓ)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법

Country Status (14)

Country Link
EP (1) EP2152669A1 (https=)
JP (1) JP5698887B2 (https=)
KR (1) KR20100017565A (https=)
CN (1) CN101679237A (https=)
AU (1) AU2008248168B2 (https=)
BR (1) BRPI0810330A2 (https=)
CA (1) CA2686033A1 (https=)
EA (1) EA019031B1 (https=)
IL (1) IL201627A (https=)
MX (1) MX2009011787A (https=)
NZ (1) NZ580948A (https=)
UA (1) UA99913C2 (https=)
WO (1) WO2008137087A1 (https=)
ZA (1) ZA200907643B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA95644C2 (ru) 2006-07-25 2011-08-25 Сефалон, Инк. Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
CA2712885A1 (en) * 2008-01-30 2009-08-06 Cephalon, Inc. Substituted pyridazine derivatives which have histamine h3 antagonist activity
EP3237408B1 (en) * 2014-12-23 2018-10-31 Cephalon, Inc. Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives
JP7413363B2 (ja) * 2018-09-07 2024-01-15 サノフイ メチル６－（２，４－ジクロロフェニル）－５－［４－［（３ｓ）－１－（３－フルオロプロピル）ピロリジン－３－イル］オキシフェニル］－８，９－ジヒドロ－７ｈ－ベンゾ［７］アヌレン－２－カルボキシレートの調製方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
EP1739104B1 (en) 2004-03-08 2014-07-09 Japan Science and Technology Agency Polymer-supported metal cluster compositions
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
CA2566526C (en) 2004-06-02 2012-10-23 F. Hoffmann-La Roche Ag Naphthaline derivatives useful as histamine-3-receptor ligands
WO2006059778A1 (ja) 2004-12-01 2006-06-08 Banyu Pharmaceutical Co., Ltd. 置換ピリドン誘導体
EP1831173B1 (en) 2004-12-17 2011-01-26 Janssen Pharmaceutica NV Tetrahydroisoquinoline compounds for treatment of cns disorders
CN101107231A (zh) 2005-01-21 2008-01-16 先灵公司 用作组胺h3拮抗剂的咪唑和苯并咪唑衍生物
CA2602336A1 (en) 2005-03-31 2006-10-05 Ucb Pharma S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CA2627234A1 (en) 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
DK1988777T3 (da) 2006-02-09 2012-01-16 Athersys Inc Pyrazoler til behandling af fedme og andre cns-lidelser
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
WO2007105053A2 (en) 2006-03-13 2007-09-20 Pfizer Products Inc. Tetralines antagonists of the h-3 receptor
EP2035372A1 (en) 2006-06-29 2009-03-18 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
UA95644C2 (ru) * 2006-07-25 2011-08-25 Сефалон, Инк. Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний

Also Published As

Publication number Publication date
JP5698887B2 (ja) 2015-04-08
UA99913C2 (ru) 2012-10-25
EA019031B1 (ru) 2013-12-30
CA2686033A1 (en) 2008-11-13
EP2152669A1 (en) 2010-02-17
IL201627A0 (en) 2010-05-31
ZA200907643B (en) 2014-03-26
MX2009011787A (es) 2009-11-13
NZ580948A (en) 2011-04-29
AU2008248168B2 (en) 2013-03-21
CN101679237A (zh) 2010-03-24
BRPI0810330A2 (pt) 2014-10-14
WO2008137087A1 (en) 2008-11-13
EA200971019A1 (ru) 2010-04-30
JP2010526142A (ja) 2010-07-29
IL201627A (en) 2014-06-30
AU2008248168A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
JP6491393B2 (ja) ヒストン脱アセチル化酵素６阻害剤としての１，３，４−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物
JP4853965B2 (ja) アダマンタン誘導体およびアザビシクロオクタン誘導体およびアザビシクロノナン誘導体、ならびにこれらの調製方法およびｄｐｐ−ｉｖ阻害剤としてのこれらの使用
CA2861202C (en) Nicotinamide derivatives or salt thereof having syk-inhibitory activity
TW422842B (en) New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
AU2021308344B2 (en) Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
CA2637530A1 (en) Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
JP2019065037A (ja) ヒストン脱アセチル化酵素阻害剤
JP2012519196A (ja) スルホニル化されたテトラヒドロアゾロピラジンおよびその医薬としての使用
CN102112449A (zh) 苯基或吡啶基取代的吲唑衍生物
KR20100093103A (ko) 고지혈증 또는 동맥경화증과 같은 질환의 치료에 유용한 ｃετρ 억제제로서의 1,2-이치환된 4-벤질아미노-피롤리딘 유도체
KR20230158007A (ko) 항바이러스 화합물
NZ544046A (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
AU2010215524A1 (en) Novel ortho-aminoamides for the treatment of cancer
MX2011003533A (es) Compuestos novedosos como bloqueadores del canal de calcio.
CA2791431A1 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
JP5457450B2 (ja) 迅速解離性ドーパミン２受容体拮抗薬としてのピペラジン−１−イル−トリフルオロメチル−置換−ピリジン
KR20100017565A (ko) (ｒ)-2-메틸피롤리딘 및 (ｓ)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법
AU2012229859C1 (en) Nitrogen-containing saturated heterocyclic compound
CA2500115A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
CN101374810A (zh) α7烟碱型乙酰胆碱受体的调节剂及其治疗用途
JPH11240832A (ja) アミド若しくはアミン誘導体
ZA200700950B (en) Pyrrole derivatives, their preparation and their therapeutic use
AU2020386151B2 (en) Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synuclein
ES2396557T3 (es) Derivado de benciloxipropilamina

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20091202

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130423

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140529

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150420

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150902

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150420

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20140529

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I